Upload File

The top documents tagged [dose groups]

September 16, 2005 Statistical Methods for Testing Carcinogenic Potential of New Drugs in Animal Carcinogenicity Studies Hojin Moon, Ph.D. HMoonnctr.fda.gov
September 16, 2005 Statistical Methods for Testing Carcinogenic Potential of New Drugs in Animal Carcinogenicity Studies Hojin Moon, Ph.D. HMoonnctr.fda.gov
217 views
Issues and Experience in Analyzing Transgenic Mouse Carcinogenicity Studies: An Industry Perspective Ronald Menton Wyeth Research 2005 FDA/Industry Statistics
Issues and Experience in Analyzing Transgenic Mouse Carcinogenicity Studies: An Industry Perspective Ronald Menton Wyeth Research 2005 FDA/Industry Statistics
220 views
Biomarkers and Surrogate Endpoints in Drug Development Technical and Regulatory Considerations Biomarkers and Surrogate Endpoints in Drug Development Technical
Biomarkers and Surrogate Endpoints in Drug Development Technical and Regulatory Considerations Biomarkers and Surrogate Endpoints in Drug Development Technical
223 views
Real-Time Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) Analysis Jelena Brkic BIOL5081
Real-Time Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) Analysis Jelena Brkic BIOL5081
225 views
Animal toxicology studies
Animal toxicology studies
23.833 views
Characterization of inflammation and immune cell modulation induced by low- dose LPS administration to healthy volunteers M.R. Dillingh 1, E.P. van Poelgeest
Characterization of inflammation and immune cell modulation induced by low- dose LPS administration to healthy volunteers M.R. Dillingh 1, E.P. van Poelgeest
218 views
American Conference on Pharmacometics –San Diego, CA; April 3-6 2011 Population PK modeling incorporating enzyme induction mechanism to guide the design
American Conference on Pharmacometics –San Diego, CA; April 3-6 2011 Population PK modeling incorporating enzyme induction mechanism to guide the design
213 views
John C. O’Connor DuPont Haskell Laboratory for Health and Environmental Sciences The 15-Day Intact Adult Male Assay As An Alternative Tier I Screening
John C. O’Connor DuPont Haskell Laboratory for Health and Environmental Sciences The 15-Day Intact Adult Male Assay As An Alternative Tier I Screening
216 views
Human endotoxin model – introduction
Human endotoxin model – introduction
33 views
Organized and Effective Interpretation of Clinical Laboratory Data: Graphs Make a Difference Robert Gordon Biostatistics and Medical Safety Johnson & Johnson
Organized and Effective Interpretation of Clinical Laboratory Data: Graphs Make a Difference Robert Gordon Biostatistics and Medical Safety Johnson & Johnson
229 views
Drug Supply Management for Adaptive Trials Micheline Marshall (Pfizer) Nancy Burnham (GlaxoSmithKline) NitinPatel (Cytel Inc) March 12, 2010 On behalf
Drug Supply Management for Adaptive Trials Micheline Marshall (Pfizer) Nancy Burnham (GlaxoSmithKline) NitinPatel (Cytel Inc) March 12, 2010 On behalf
221 views
111 Department of Statistics TEXAS A&M UNIVERSITY STAT 211 Instructor: Keith Hatfield
111 Department of Statistics TEXAS A&M UNIVERSITY STAT 211 Instructor: Keith Hatfield
231 views